Ichor is a specialty plasma-derived biopharmaceuticals firm dedicated to developing and commercializing high-grade plasma derivatives to improve people's quality of life and save lives. Ichor runs on an integrated platform that combines a cutting-edge fractionation facility that can produce life-saving medicines by the strictest international standards with a platform for the safe and dependable collection of high-quality human plasma.